COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
| Main Authors: | , , , |
|---|---|
| Format: | Journal article |
| Published: |
2010
|
| _version_ | 1797079466995875840 |
|---|---|
| author | Purcaru, O Taylor, P Emery, P Palmer, S |
| author_facet | Purcaru, O Taylor, P Emery, P Palmer, S |
| author_sort | Purcaru, O |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T00:46:16Z |
| format | Journal article |
| id | oxford-uuid:84c46a12-5fca-4972-823f-8d5336588f26 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T00:46:16Z |
| publishDate | 2010 |
| record_format | dspace |
| spelling | oxford-uuid:84c46a12-5fca-4972-823f-8d5336588f262022-03-26T21:53:14ZCOST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOMJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:84c46a12-5fca-4972-823f-8d5336588f26Symplectic Elements at Oxford2010Purcaru, OTaylor, PEmery, PPalmer, S |
| spellingShingle | Purcaru, O Taylor, P Emery, P Palmer, S COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM |
| title | COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM |
| title_full | COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM |
| title_fullStr | COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM |
| title_full_unstemmed | COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM |
| title_short | COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM |
| title_sort | cost effectiveness of certolizumab pegol plus methotrexate or as monotherapy for the treatment of active rheumatoid arthritis in the united kingdom |
| work_keys_str_mv | AT purcaruo costeffectivenessofcertolizumabpegolplusmethotrexateorasmonotherapyforthetreatmentofactiverheumatoidarthritisintheunitedkingdom AT taylorp costeffectivenessofcertolizumabpegolplusmethotrexateorasmonotherapyforthetreatmentofactiverheumatoidarthritisintheunitedkingdom AT emeryp costeffectivenessofcertolizumabpegolplusmethotrexateorasmonotherapyforthetreatmentofactiverheumatoidarthritisintheunitedkingdom AT palmers costeffectivenessofcertolizumabpegolplusmethotrexateorasmonotherapyforthetreatmentofactiverheumatoidarthritisintheunitedkingdom |